- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
Anonymous HCP alleged late-night hotel bar entertaining at ISTH Amsterdam. Panel accepted Bayer account of 4 drinks bought near midnight while waiting…
A senior sales email about CRM data entry also set “2+ target interactions/day” and “5–7 total/day” without clearly distinguishing call rates from…
Sativex POM ads appeared on a US creative media site after an awards submission. PMCPA said the Code applied (UK cost referenced)…
A Stelara bound-in journal advert ran with November 2014 prescribing information after the PI was updated in June 2015. Despite publisher error,…
Anonymous rep alleged overcalling pressure and uncertified materials. Panel found uncertified briefing slides (Clauses 14.1/15.9/9.1). Appeal Board added Clause 2 breach after…
Ipsen’s Dysport leavepieces compared dose ratios vs other BoNT-A products using SPC data and a 2012 systematic review. PMCPA found misleading implied…
PMCPA ruled Otsuka breached Clauses 22.1, 9.1 and 2 after a senior employee arranged alcoholic drinks for an apparently intoxicated meeting delegate…
Anonymous HCP challenged Seretide promotion using TORCH secondary endpoints despite non-significant primary endpoint (p=0.052). PMCPA found some materials contextualised appropriately, but others…
A nurse complained that entry to a Galderma-backed aesthetics meeting required buying two Emervel fillers. The event promoted Azzalure/Pliaglis, included unlicensed toxin…
A public complaint alleged Recordati failed to disclose silodosin trial results on time. The PMCPA Panel found disclosure obligations were met (or…
Roche admitted a paid-for page in a consumer breast cancer magazine promoted Herceptin and Avastin to the public. PMCPA ruled it was…
Bayer challenged a Lixiana leavepiece. Panel found breaches for an unclear VTE “initiation” dosing-transition claim and a misleading 30‑day pill-burden graph (vs…
BMS was accused of promoting Daklinza (POM) to the public by placing a promotional leavepiece on seats at conference sessions. The Panel…
GSK was cleared for an independent MIMS article and most materials, but breached the Code for two certified HCP presentations that cited…
A health professional challenged AbbVie’s Humira ad claim “Fast symptom relief from week 1 (CD) and week 2 (UC)” as an implied…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.